Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Cash from Financing Activities (2022 - 2026)

TriSalus Life Sciences has reported Cash from Financing Activities over the past 5 years, most recently at $42.4 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities rose 337.5% year-over-year to $42.4 million; the TTM value through Mar 2026 reached $63.5 million, up 42.62%, while the annual FY2025 figure was $30.8 million, 18.91% down from the prior year.
  • Cash from Financing Activities for Q1 2026 was $42.4 million at TriSalus Life Sciences, up from $277000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $42.4 million in Q1 2026 and troughed at $43000.0 in Q4 2023.
  • A 5-year average of $10.5 million and a median of $5.9 million in 2022 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 99.27% in 2023 and later surged 6862.79% in 2024.
  • Year by year, Cash from Financing Activities stood at $5.9 million in 2022, then plummeted by 99.27% to $43000.0 in 2023, then surged by 6862.79% to $3.0 million in 2024, then tumbled by 90.75% to $277000.0 in 2025, then surged by 15201.44% to $42.4 million in 2026.
  • Business Quant data shows Cash from Financing Activities for TLSI at $42.4 million in Q1 2026, $277000.0 in Q4 2025, and $82000.0 in Q3 2025.